During the past decade, Opca bolnica Bjelovar conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 4 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Opca bolnica Bjelovar" #1 sponsor was "Shire" with 5 trials, followed by "Janssen Research & Development, LLC" with 4 trials sponsored, "Bjelovar General Hospital" with 1 trials sponsored, "Immunic AG" with 1 trials sponsored and "InDex Pharmaceuticals" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Opca bolnica Bjelovar" are "Crohn's Disease" (5 trials), "Ulcerative Colitis" (5 trials), "Colitis, Ulcerative" (1 trials), "Crohn Disease" (1 trials) and "Rationalization" (1 trials). Many other conditions were trialed in "Opca bolnica Bjelovar" in a lesser frequency.

Most popular intervention types in "Opca bolnica Bjelovar" are "Drug" (11 trials), "Other" (4 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Ontamalimab" (4 trials), "Guselkumab" (3 trials), "Golimumab" (2 trials) and "Guselkumab Dose 1" (2 trials). Other intervention names were less common.

The vast majority of trials in "Opca bolnica Bjelovar" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Opca bolnica Bjelovar". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Opca bolnica Bjelovar, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Opca bolnica Bjelovar, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".